Loading stock data…
$3.78+0.47 (+14.43%)
Conexeu Sciences Inc.
| Metric (USD) | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — |
| Operating Income | -$2.38M↓ | -$1.72M↓ | -$456,055↓ | -$332,721 |
| Net Income | -$2.30M↓ | -$1.72M↓ | -$458,050↓ | -$290,064 |
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (E...